Acceptability and experience of a personalised proteomic risk intervention for type 2 diabetes in primary care: qualitative interview study with patients and healthcare providers.
Stephanie HoneyRichard D NealMichael MessengerSamuel G SmithPublished in: Primary health care research & development (2022)
The personalised proteomic risk intervention was generally acceptable and the experience was positive. The personalised nature of the report was welcomed, especially the way it provided a holistic approach to risks of organ damage and lifestyle factors. Insights were provided as to how this may change behaviour. Some participants reported difficulties in understanding the format of the presentation of risk and expressed surprise at receiving risk estimates for conditions other than type 2 diabetes. Personalised proteomic risk interventions have the potential to provide holistic and comprehensive assessments of risk factors and lifestyle factors which may lead to positive behaviour change.
Keyphrases
- type diabetes
- primary care
- healthcare
- risk factors
- cardiovascular disease
- randomized controlled trial
- metabolic syndrome
- end stage renal disease
- physical activity
- oxidative stress
- systematic review
- chronic kidney disease
- skeletal muscle
- peritoneal dialysis
- adipose tissue
- health insurance
- prognostic factors
- general practice